Thyroid Cancer Burden in China: 1990 to 2021 Trends and 15‐Year Projections Against Global Trends
The thyroid cancer burden in China is characterized by rapidly rising incidence and stagnating mortality decline, a pattern distinct from global trends and likely driven by intensified detection. This escalating burden necessitates public health strategies focused on optimizing screening practices and managing overdiagnosis.
Authors
- Hai‐Long Tan (ORCID: https://orcid.org/0000-0002-3345-5277)
- Jing Lin (ORCID: https://orcid.org/0000-0001-9085-8307)
- Zhiyong Qin (ORCID: https://orcid.org/0000-0002-7434-7985)
- Huan Ge (ORCID: https://orcid.org/0000-0003-0434-0822)
Institutions
- Central South University (CN)
- Xinjiang Medical University (CN)
- Tumor Hospital of Xinjiang Medical University (CN)
- The First People's Hospital of Changde (CN)
- National Clinical Research (US)
- Xiangya Hospital Central South University (CN)
Publication Details
- Journal
- OTO Open
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1002/oto2.70187
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Central South University
- Xinjiang Medical University
- Xiangya Hospital, Central South University